[Neuroendocrine factors in pathogenesis of motion sickness and the protective effect of drugs].
The paper presents a generalization of many-year complex investigations performed at various departments of the Institute of Medico-Biological Problems (Moscow) and various laboratories and institutes of the Ministry of Public Health and the Russian Academy of Medical Sciences, devoted to the pathogenesis of motion disease (sea sickness, vestibulo vegetative syndrome, various forms of kinetosis). The main attention is given to interpretation of the mechanisms of therapeutic and prophylactic action of drugs used for the treatment of such disorders. In particular, the role of a hormonal component of the system of regulation of physiological functions is considered as manifested in the models of the vestibulovegetative syndrome and in the pharmacotherapy of the motion disease.
Shashkov
A V
AV
Space Medicine Center Corporation, Moscow, Russia.
Karsanova
S K
SK
Iasnetsov
V V
VV
Tigranian
R A
RA
Shashkov
V S
VS
D000328:Adult; D001341:Autonomic Nervous System / Q000187:drug effects / Q000503:physiopathology*; D004703:Endocrine System / Q000187:drug effects / Q000503:physiopathology*; D006728:Hormones / Q000097:blood*; D006801:Humans; D008297:Male; D009041:Motion Sickness / Q000175:diagnosis / Q000503:physiopathology* / Q000517:prevention & control*; D014722:Vestibule, Labyrinth / Q000503:physiopathology*
D006728:Hormones